Discover how the FDA’s new guidance on Prescription Drug Use-Related Software (PDURS) can drive brand differentiation and commercial success in the pharmaceutical industry. https://ow.ly/Ic8v50SPo0T In our new thought leadership article, Manuel Jurado from The Dedham Group and Austin Speier and Steven L. from Click Therapeutics, Inc. explore the opportunities this guidance presents. Click the link in this post for the insights.
The Dedham Group’s Post
More Relevant Posts
-
Please take a few minutes to read this article on the FDAs guidance on PDURs and how this technology can drive brand differentiation and commercial success. If you would like to hear our perspective, please reach out and let us know. #dedhamgroup #norstella Manuel Jurado
Discover how the FDA’s new guidance on Prescription Drug Use-Related Software (PDURS) can drive brand differentiation and commercial success in the pharmaceutical industry. https://ow.ly/Ic8v50SPo0T In our new thought leadership article, Manuel Jurado from The Dedham Group and Austin Speier and Steven L. from Click Therapeutics, Inc. explore the opportunities this guidance presents. Click the link in this post for the insights.
To view or add a comment, sign in
-
Are you at the Advanced Therapies Congress? Pop by Stand 35 to meet our team and learn how we can support the design of your pharmaceutical manufacturing facilities. Don't forget that Edward Fahey will be explaining the intricacies of pharmaceutical manufacturing facility design at 14:40 today. Catch him in Track 10 – Cell Therapy Manufacturing. #AdvancedManufacturing #AdvancedTherapies #AdvancedTherapiesCongress #AdTherapies24
To view or add a comment, sign in
-
Data-driven decisions are key in the healthcare industry. Did you know the Brazilian market is projected to grow by 9.8% this year? This surge, coupled with a complex public-private healthcare system, presents a unique opportunity for pharmaceutical companies. In our latest article, written by Dr. Fisiologia on behalf of Pharma Meeting Brazil , we discuss more about all Brazil's advantages for foreign pharmaceutical companies. Download now to read the full article here: https://lnkd.in/dMwapyDv
To view or add a comment, sign in
-
Data-driven decisions are key in the healthcare industry. Did you know the Brazilian market is projected to grow by 9.8% this year? This surge, coupled with a complex public-private healthcare system, presents a unique opportunity for pharmaceutical companies. In our latest article, written by Dr. Fisiologia on behalf of Pharma Meeting Brazil, we discuss more about all Brazil's advantages for foreign pharmaceutical companies. Download now to read the full article here: https://lnkd.in/dMwapyDv
To view or add a comment, sign in
-
The article, "U.S. FDA issues game-changing program to help expedite new therapeutics to market," by Angela Johnson, discusses the U.S. FDA's introduction of a groundbreaking program aimed at accelerating the approval process for new therapeutics, to facilitate the entry into the market. This initiative is set to revolutionize the pharmaceutical industry by streamlining regulatory procedures and expediting the availability of innovative treatments for patients. Through simplifying regulatory processes and increasing transparency, the FDA's program offers a significant opportunity for CDMO companies like KSB to accelerate the development and commercialization of conjugated-drug therapies. To learn more, visit: https://lnkd.in/gMxW4iME Article link: https://lnkd.in/g5pM6Wqi #USFDA #DrugDevelopment #RegulatoryAffairs #CDMO
To view or add a comment, sign in
-
As the 2024 PDA - Parenteral Drug Association Annual Meeting is rapidly approaching, we at Lindström are thrilled to announce our sponsorship of this esteemed event. Our commitment to innovation and excellence in the pharmaceutical industry aligns perfectly with the PDA's mission to advance pharmaceutical and biopharmaceutical technology globally. We are eagerly anticipating the opportunity to connect with delegates, attendees, and fellow industry professionals. Our team will be on hand to discuss the latest trends, share insights, and explore how Lindström's solutions can support the critical work being done across the parenteral drug sector. #pdac2024 #contaminationcontrol #usfda #cleanroomlaundry Manas KumarRamdev AgarwalJayant Roy #regulatorycompliance #gmpcompliance #annex1
To view or add a comment, sign in
-
Honored and excited to be presenting at the 19th Annual Garnet E. Peck Symposium. The theme is around "Digital Transformation in the Pharmaceutical Industry". My presentation is titled "Industry 4.0 Revolution Meets Pharmaceutical Transformation: Novel Solutions for Pressing Patient Needs"
📣 Last call! Join us at the Garnet E. Peck Symposium as we delve into the exciting world of Digital Transformation in the Pharmaceutical Industry. Today is the final day to register. https://loom.ly/8zcX9qw #pharmacysgiantleap
To view or add a comment, sign in
-
Latest pharma Innovations - There have been many significant innovations in the pharmaceutical industry in recent years. Some examples of the latest pharmaceutical innovations include: Overall, the pharmaceutical industry is constantly evolving, and there are many exciting innovations that have the potential to revolutionize the treatment of a wide range of diseases and conditions. These innovations are helping to improve the effectiveness of treatments, reduce the risk of side effects, and improve patient outcomes. https://lnkd.in/dH8SumWN
To view or add a comment, sign in
-
Innovation and Pharmaceutical Development: Pioneering New Frontiers in Medicine In today's rapidly evolving pharmaceutical landscape, innovation stands as the cornerstone of progress and success. The realm of pharmaceutical development encompasses a multifaceted journey, from initial drug discovery to optimizing drug delivery mechanisms. This article delves into the pivotal role of innovation in shaping the future of medicine, drawing insights from esteemed thought leaders and well-established literature. https://lnkd.in/dmy_Pz_x
To view or add a comment, sign in
-
Discover how Ingenious e-Brain’s strategic insights enabled a pharmaceutical company to effectively position Drug X for optimal pricing and acceptance in the competitive oncology market. Our evidence-based approach guided the client through complex pricing strategies, ensuring the successful navigation of payer expectations. Read the detailed case study to explore further: https://lnkd.in/dfFmCE_U #pharmastrategy #oncologymarket #drugpricing #payerstrategy #pharmaceuticals #marketaccess #evidencebased #healthcareconsulting #pricingstrategy #pharmacasestudy #futureproofingbusinesses
To view or add a comment, sign in
17,290 followers